Monitor closing conditions and integration progress; the acquisition adds a profitable revenue stream but execution risk remains. Watch for subsequent acquisitions in the announced programme and any updates on deploying Davion's monitoring technologies into HSH's operations.
Price Chart
Executive Summary
Davion Healthcare Plc announces a $13.5M acquisition of Healthcare Stat Homecare Inc. (HSH), a profitable home healthcare provider with $11.6M in gross receipts and $1.9M in ordinary business income for 2025. The deal is structured as $8M cash plus $5.5M in Davion shares, expected to close by year-end 2026, and marks the first of a planned acquisition program to build a diversified healthcare group.
Key Financial Metrics
Key Facts
- Total consideration $13.5 million: $8 million cash + $5.5 million in Davion shares at $13/share.
- HSH reported gross receipts of ~$11.6M and ordinary business income of ~$1.9M (unaudited) for FY2025.
- Acquisition expected to close on or before 31 December 2026.
- Davion's market cap is $75M, making the deal value ~18% of market cap.
- HSH provides skilled nursing, home health aide, rehabilitation services; holds JCAHO accreditation, Medicare/Medicaid certifications.
- First in a planned programme of acquisitions of revenue-generating, profitable healthcare businesses over the coming year.
Financial Impact
Deal value $13.5M (18% of Davion's $75M market cap); HSH's 2025 gross receipts $11.6M and ordinary business income $1.9M provide a meaningful revenue and earnings base for Davion.
Risk Factors
- Integration risk: combining a technology developer with a home healthcare services provider may face operational and cultural challenges.
- Dilution from share issuance: $5.5M in shares at $13/share implies ~423,077 new shares (dilution ~5.7% based on current market cap).
- Forward-looking statements about planned acquisitions are aspirational and may not materialize.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3391143 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 3d ago | 6-K | $2.69 | awaiting T+20 | awaiting T+20 | $1.68 (−37.55%) |
Oct 29, 2026 3d ago | Press Release | $2.69 | awaiting T+20 | awaiting T+20 | $1.68 (−37.55%) |
Oct 27, 2026 5d ago | 6-K | $3.00 | awaiting T+20 | awaiting T+20 | $1.68 (−44.00%) |
Oct 26, 2026 6d ago | Press Release | $4.07 | awaiting T+20 | awaiting T+20 | $1.68 (−58.72%) |
Oct 20, 2026 12d ago | 6-K | No price | awaiting T+20 | awaiting T+20 | No price |
Sep 15, 2026 6w ago | 6-K | No price | awaiting T+20 | awaiting T+20 | No price |
Apr 30, 2026 26w ago | 20-F | No price | awaiting T+20 | awaiting T+20 | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers